GlassScriptPhysician profile
John P Chapman
NPI 1891227591
$42,282.34
in general payments reported to CMS, 2019-2025
7 companies · $347 in 2025
The $347 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $31K · 2023: $10K · 2024: $205 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $10K · Food and Beverage: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,100.00 |
| Food and Beverage | $776.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $20,352.43 | 2022-2023 | Bone Anchors With Arthroscopic Delivery System |
| Arthrex, INC. | $20,000.00 | 2022 | |
| Alon Medical Technology | $1,219.32 | 2022-2023 | |
| Stryker Corporation | $472.65 | 2022-2025 | Flexband, Procinch, T2 Alpha |
| Cgg Medical INC | $177.67 | 2025 | |
| Ferring Pharmaceuticals INC. | $35.12 | 2024-2025 | Adstiladrin |
| Depuy Synthes Sales INC. | $25.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Chapman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.